235 related articles for article (PubMed ID: 16856007)
1. Erythropoietin or darbepoetin for patients with cancer.
Bohlius J; Wilson J; Seidenfeld J; Piper M; Schwarzer G; Sandercock J; Trelle S; Weingart O; Bayliss S; Brunskill S; Djulbegovic B; Benett CL; Langensiepen S; Hyde C; Engert E
Cochrane Database Syst Rev; 2006 Jul; (3):CD003407. PubMed ID: 16856007
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin for patients with malignant disease.
Bohlius J; Langensiepen S; Schwarzer G; Seidenfeld J; Piper M; Bennet C; Engert A
Cochrane Database Syst Rev; 2004; (3):CD003407. PubMed ID: 15266483
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin or darbepoetin for patients with cancer.
Tonia T; Mettler A; Robert N; Schwarzer G; Seidenfeld J; Weingart O; Hyde C; Engert A; Bohlius J
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003407. PubMed ID: 23235597
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer.
Lambin P; Ramaekers BL; van Mastrigt GA; Van den Ende P; de Jong J; De Ruysscher DK; Pijls-Johannesma M
Cochrane Database Syst Rev; 2009 Jul; (3):CD006158. PubMed ID: 19588382
[TBL] [Abstract][Full Text] [Related]
6. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.
Strippoli GF; Manno C; Schena FP; Craig JC
Cochrane Database Syst Rev; 2003; (1):CD003967. PubMed ID: 12535495
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
[TBL] [Abstract][Full Text] [Related]
8. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Khan I; Rabindranath K; Vale L; Wallace S; Macleod A
Cochrane Database Syst Rev; 2005 Jul; (3):CD003266. PubMed ID: 16034896
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.
Bohlius J; Wilson J; Seidenfeld J; Piper M; Schwarzer G; Sandercock J; Trelle S; Weingart O; Bayliss S; Djulbegovic B; Bennett CL; Langensiepen S; Hyde C; Engert A
J Natl Cancer Inst; 2006 May; 98(10):708-14. PubMed ID: 16705125
[TBL] [Abstract][Full Text] [Related]
11. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
12. The blue cross blue shield assessment technology review: summary of findings.
Bennett CL
Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.
Bohlius J; Schmidlin K; Brillant C; Schwarzer G; Trelle S; Seidenfeld J; Zwahlen M; Clarke MJ; Weingart O; Kluge S; Piper M; Napoli M; Rades D; Steensma D; Djulbegovic B; Fey MF; Ray-Coquard I; Moebus V; Thomas G; Untch M; Schumacher M; Egger M; Engert A
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007303. PubMed ID: 19588423
[TBL] [Abstract][Full Text] [Related]
14. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.
Strippoli GF; Navaneethan SD; Craig JC
Cochrane Database Syst Rev; 2006 Oct; (4):CD003967. PubMed ID: 17054191
[TBL] [Abstract][Full Text] [Related]
15. Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.
Coronado Daza J; Martí-Carvajal AJ; Ariza García A; Rodelo Ceballos J; Yomayusa González N; Páez-Canro C; Loza Munárriz C; Urrútia G
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011122. PubMed ID: 26671531
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.
Bohlius J; Langensiepen S; Schwarzer G; Seidenfeld J; Piper M; Bennett C; Engert A
J Natl Cancer Inst; 2005 Apr; 97(7):489-98. PubMed ID: 15812074
[TBL] [Abstract][Full Text] [Related]
17. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery.
Devon KM; McLeod RS
Cochrane Database Syst Rev; 2009 Jan; (1):CD007148. PubMed ID: 19160325
[TBL] [Abstract][Full Text] [Related]
18. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
[TBL] [Abstract][Full Text] [Related]
19. Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy.
Demetri GD
Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):31-7. PubMed ID: 11308272
[TBL] [Abstract][Full Text] [Related]
20. Darbepoetin alfa: a review of its use in the treatment of anaemia in patients with cancer receiving chemotherapy.
Siddiqui MA; Keating GM
Drugs; 2006; 66(7):997-1012. PubMed ID: 16740021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
